NLRP3 inflammasome-modulated angiogenic function of EPC via PI3K/ Akt/mTOR pathway in diabetic myocardial infarction

NLRP3 inflammasome-modulated angiogenic function of EPC via PI3K/ Akt/mTOR pathway in diabetic myocardial infarction

Abstract Background Inflammatory diseases impair the reparative properties of endothelial progenitor cells (EPC); however, the involvement of diabetes in EPC dysfunction associated with myocardial infarction (MI) remains unknown. Methods A model was established combining high-fat diet (HFD)/streptoz...

Full description

Saved in:

Bibliographic Details
Main Authors:	Jia-Peng Li, Shu Qiu, Guang-Jie Tai, Yi-Ming Liu, Wei Wei, Meng-Meng Fu, Pan-Qi Fang, Joseph Nicolao Otieno, Tungalag Battulga, Xiao-Xue Li, Ming Xu
Format:	Article
Language:	English
Published:	BMC 2025-01-01
Series:	Cardiovascular Diabetology
Subjects:	Myocardial infarction Diabetes Endothelial progenitor cell NLRP3 inflammasome Angiogenesis
Online Access:	https://doi.org/10.1186/s12933-024-02541-3
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

New insight into the role of the pathway NLRP1 and NLRP3 inflammasomes and IL-33 in ultraviolet-induced cutaneous carcinogenesis
by: Aleksandra Lesiak, et al.
Published: (2025-01-01)

Formononetin ameliorates polycystic ovary syndrome through suppressing NLRP3 inflammasome
by: Zhuo Liu, et al.
Published: (2025-01-01)

NLRP3 Inflammasome-Mediated Osteoarthritis: The Role of Epigenetics
by: Yuzhou Liu, et al.
Published: (2025-01-01)

The effect of NLRP3 inflammasome on cardiovascular prognosis in patients with acute coronary syndrome
by: De-Gang Mo, et al.
Published: (2025-01-01)

Apigenin inhibits NLRP3 inflammasome activation in monocytes and macrophages independently of CD38
by: Knut Husø Lauritzen, et al.
Published: (2025-01-01)

Correlation and diagnostic significance of CD4 T cell subsets and NLRP3 inflammasome in ulcerative colitis: the role of the NLRP3/T-bet/GATA3 axis
by: Yingnan Hu, et al.
Published: (2025-01-01)

Metformin Ameliorates Ulcerative Colitis Through Inhibiting NLRP3 Inflammasome Activation
by: Cao R, et al.
Published: (2025-02-01)

α-amanitin induces hepatotoxicity via PPAR-γ inhibition and NLRP3 inflammasome activation
by: Haowei Wang, et al.
Published: (2025-01-01)

Gut microbiota: a novel target for exercise-mediated regulation of NLRP3 inflammasome activation
by: Jun Chen, et al.
Published: (2025-01-01)

Global Research Trends and Focus on the Link Between Heart Failure and NLRP3 Inflammasome: A Bibliometric Analysis From 2010 to 2024
by: Lian Y, et al.
Published: (2025-02-01)

USP22 inhibits microglial M1 polarization by regulating the PU.1/NLRP3 inflammasome pathway
by: Ming-chen Yu, et al.
Published: (2025-01-01)

The Role and the Regulation of NLRP3 Inflammasome in Irritable Bowel Syndrome: A Narrative Review
by: Arezina Kasti, et al.
Published: (2025-01-01)

The ABC transporter A7 modulates neuroinflammation via NLRP3 inflammasome in Alzheimer’s disease mice
by: Irene Santos-García, et al.
Published: (2025-01-01)

Verbascoside Inhibits the Activation of NLRP3 Inflammasome and Improves BV-2 Cell Inflammatory Damage
by: Wenjing HUANG, et al.
Published: (2025-02-01)

Navigating from cellular phenotypic screen to clinical candidate: selective targeting of the NLRP3 inflammasome
by: Rosalie Matico, et al.
Published: (2024-12-01)

Baicalein inhibits NLRP3 inflammasome activation and mitigates placental inflammation and oxidative stress in gestational diabetes mellitus
by: Yao Jun, et al.
Published: (2024-12-01)

Glycemic Control in Type 2 Diabetes Mellitus Patients Could Affect NLRP3 Inflammasome Level
by: Refif Sabih Al-Shawk, et al.
Published: (2024-12-01)

CMPK2 promotes NLRP3 inflammasome activation via mtDNA‐STING pathway in house dust mite‐induced allergic rhinitis
by: YaoMing Zheng, et al.
Published: (2025-01-01)

5-deoxy-rutaecarpine protects against LPS-induced acute lung injury via inhibiting NLRP3 inflammasome-related inflammation
by: Jinque Luo, et al.
Published: (2025-01-01)

NLRP3 inflammasome activation and disruption of IRS-1/PI3K/AKT signaling: Potential mechanisms of arsenic-induced pancreatic beta cells dysfunction in rats
by: Yonglian Liu, et al.
Published: (2025-01-01)

Chemerin-9 is neuroprotective in APP/PS1 transgenic mice by inhibiting NLRP3 inflammasome and promoting microglial clearance of Aβ
by: Jiawei Zhang, et al.
Published: (2025-01-01)

NLRP3 is a BMI-independent mediator of stable COPD
by: Yonca Gungor, et al.
Published: (2025-01-01)

Helicobacter pylori infection promotes M1 macrophage polarization and gastric inflammation by activation of NLRP3 inflammasome via TNF/TNFR1 axis
by: Xiao Fei, et al.
Published: (2025-01-01)

Macropinocytosis enhances foamy macrophage formation and cholesterol crystallization to activate NLRP3 inflammasome after spinal cord injury
by: Chenxi Zhang, et al.
Published: (2025-02-01)

Dysregulation of the NLRP3 Inflammasome and Promotion of Disease by IL-1β in a Murine Model of Sandhoff Disease
by: Nick Platt, et al.
Published: (2025-01-01)

The role of the interplay between macrophage glycolytic reprogramming and NLRP3 inflammasome activation in acute lung injury/acute respiratory distress syndrome
by: Lan Luo, et al.
Published: (2024-12-01)

ROS-regulated SUR1-TRPM4 drives persistent activation of NLRP3 inflammasome in microglia after whole-brain radiation
by: Yuan Chang, et al.
Published: (2025-01-01)

Active ingredients of traditional Chinese medicine inhibit NOD-like receptor protein 3 inflammasome: a novel strategy for preventing and treating heart failure
by: Ruifang Lin, et al.
Published: (2025-01-01)

Decursinol angelate relieves inflammatory bowel disease by inhibiting the ROS/TXNIP/NLRP3 pathway and pyroptosis
by: Yudi Wang, et al.
Published: (2025-01-01)

The role of inflammasomes in hepatocellular carcinoma: Mechanisms and therapeutic insights
by: Valentina Arrè, et al.
Published: (2025-01-01)

NLRP3 activation maintains intestinal epithelial barrier and reduces liver injury in alcoholic liver disease mice
by: Shi‐Qing Li, et al.
Published: (2024-12-01)

Complex immunotoxic effects of T-2 Toxin on the murine spleen and thymus: Oxidative damage, inflammasomes, apoptosis, and immunosuppression
by: Mingyan Chen, et al.
Published: (2025-01-01)

NLRP3 deficiency aggravated DNFB-induced chronic itch by enhancing type 2 immunity IL-4/TSLP-TRPA1 axis in mice
by: Si-Ting Huang, et al.
Published: (2025-01-01)

Anti-Inflammatory and Anti-Migratory Effects of Morin on Non-Small-Cell Lung Cancer Metastasis via Inhibition of NLRP3/MAPK Signaling Pathway
by: Punnida Arjsri, et al.
Published: (2025-01-01)

Elaidic acid-induced intestinal barrier damage led to gut-liver axis derangement and triggered NLRP3 inflammasome in the liver of SD rats
by: Hui Liu, et al.
Published: (2024-05-01)

Lacticaseibacillus rhamnosus Fmb14 ameliorates hyperuricemia-induced hepatocyte pyroptosis via NLRP3 inflammasome cascade inhibition
by: Hongyuan Zhao, et al.
Published: (2024-07-01)

Obstructive sleep apnea, the NLRP3 inflammasome and the potential effects of incretin therapies
by: Michelle Wei, et al.
Published: (2025-01-01)

Puerariae Radix protects against ulcerative colitis in mice by inhibiting NLRP3 inflammasome activation
by: Yu Ga, et al.
Published: (2024-07-01)

Iodine activates NLRP3 inflammasomes in PBMCs of patients with autoimmune thyroiditis and regulates Th1 and Th17 cell differentiation
by: Ying Wu, et al.
Published: (2025-01-01)

Protective mechanism of safflower yellow injection on myocardial ischemia-reperfusion injury in rats by activating NLRP3 inflammasome
by: Lingmei Li, et al.
Published: (2025-01-01)